VISUAL FIELD DEFECT side effect
What is VISUAL FIELD DEFECT ?Drugs associated with VISUAL FIELD DEFECT
ABILIFY ACTONEL ACTOS ALPRAZOLAM AMIODARONE AVODART AVONEX BEXTRA BIMATOPROST CELECOX CHANTIX CIALIS CITALOPRAM CYCLOSPORINE DEFINITY DEPAKENE DEPAKOTE DOXIL DOXYCYCLINE ENBREL ESCITALOPRAM EXJADE FEMARA FLOMAX FLUTICASONE FOSAMAX IBUPROFEN LANSAP LEVAQUIN LEVITRA LUDIOMIL LYRICA MALARONE METHYLPHENIDATE MIRENA NEURONTIN NOLVADEX NORVASC OXALIPLATIN PEGASYS PRAMIPEXOLE PREVACID RAPAMUNE REBETOL REMICADE RISPERDAL RITUXIMAB ROACCUTAN SPIRIVA SPRYCEL SUTENT TADALAFIL TEGRETOL TEMODAL TRILEPTAL ULTRAVIST VALIXA VALPROIC VALTREX VIAGRA VOLTAREN XALATANVISUAL FIELD DEFECT : Tadalafil Side Effects Report #5673239-5
Physician from DENMARK reported TADALAFIL problem on Mar 12, 2008. Male patient was diagnosed with erectile dysfunction, hypercholesterolaemia and was treated with TADALAFIL. After drug was administered, patient experienced the following problems/side effects: visual field defect, . TADALAFIL dosage: 20 MG, AS NEEDED. During the same period patient was treated with SIMVASTATIN. Patient recovered.
VISUAL FIELD DEFECT : Rebetol Side Effects Report #5679909-7
REBETOL problem was reported by a Physician from FINLAND on Mar 18, 2008. Male patient, 32 years of age, was diagnosed with hepatitis c and was treated with REBETOL. After drug was administered, patient experienced the following problems/side effects: visual field defect, . REBETOL dosage: 1200 MG; PO. During the same period patient was treated with PEGASYS. Patient recovered.
VISUAL FIELD DEFECT : Spiriva Side Effects Report #5593795-5
Consumer or non-health professional from UNITED STATES reported SPIRIVA problem on Dec 26, 2007. Female patient was diagnosed with chronic obstructive pulmonary disease, anxiety, arthritis and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: visual field defect, . SPIRIVA dosage: unknown. During the same period patient was treated with XANAX, HYDROCODONE. Patient recovered.
VISUAL FIELD DEFECT : Cialis Side Effects Report #5595961-1
CIALIS problem was reported by a Physician from AUSTRALIA on Jan 11, 2008. Male patient, 65 years of age, was diagnosed with erectile dysfunction and was treated with CIALIS. After drug was administered, patient experienced the following problems/side effects: visual field defect, . CIALIS dosage: unknown. Patient recovered.
VISUAL FIELD DEFECT : Femara Side Effects Report #5597121-7
Physician from FRANCE reported FEMARA problem on Jan 14, 2008. Female patient was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: visual field defect, . FEMARA dosage: 2.5 MG, QD. Patient recovered.
VISUAL FIELD DEFECT : Femara Side Effects Report #5503663-2
FEMARA problem was reported by a Physician from FRANCE on Oct 25, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: visual field defect, . FEMARA dosage: 2.5 MG, QD. Patient recovered.
VISUAL FIELD DEFECT : Depakene Side Effects Report #5511708-9
Health Professional from FRANCE reported DEPAKENE problem on Oct 30, 2007. Male patient, 49 years of age, was diagnosed with epilepsy and was treated with DEPAKENE. After drug was administered, patient experienced the following problems/side effects: visual field defect, . DEPAKENE dosage: unknown. During the same period patient was treated with CARBAMAZEPINE. Patient recovered.
VISUAL FIELD DEFECT : Xalatan Side Effects Report #5524363-9
XALATAN problem was reported by a Consumer or non-health professional from JAPAN on Nov 14, 2007. Male patient was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: visual field defect, . XALATAN dosage: unknown. Patient recovered.
VISUAL FIELD DEFECT : Tegretol Side Effects Report #5500959-5
Health Professional from SWITZERLAND reported TEGRETOL problem on Oct 19, 2007. Male patient was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: visual field defect, . TEGRETOL dosage: 800 MG/DAY. During the same period patient was treated with DEPAKINE CHRONO. Patient recovered.
VISUAL FIELD DEFECT : Risperdal Side Effects Report #5461359-X
RISPERDAL problem was reported by a Physician from GERMANY on Sept 13, 2007. Female patient was diagnosed with schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: visual field defect, . RISPERDAL dosage: unknown. During the same period patient was treated with VALPROATE, EUTHYROX, DIPIPERONE, AKINETON. Patient was hospitalized. Patient recovered.
VISUAL FIELD DEFECT : Levitra Side Effects Report #5407109-4
Physician from UNITED STATES reported LEVITRA problem on July 31, 2007. Male patient was diagnosed with erectile dysfunction, blood pressure abnormal and was treated with LEVITRA. After drug was administered, patient experienced the following problems/side effects: visual field defect, . LEVITRA dosage: TOTAL DAILY DOSE: 20 MG UNIT DOSE: 20 MG. During the same period patient was treated with METFORMIN. Patient recovered.
VISUAL FIELD DEFECT : Norvasc Side Effects Report #5408766-9
NORVASC problem was reported by a Physician from JAPAN on July 27, 2007. Male patient, weighting 129.4 lb, was diagnosed with hypertension and was treated with NORVASC. After drug was administered, patient experienced the following problems/side effects: visual field defect, . NORVASC dosage: unknown. During the same period patient was treated with CANDESARTAN CILEXETIL, ZESTRIL, LONGES. Patient recovered.
VISUAL FIELD DEFECT : Bextra Side Effects Report #5430061-2
Consumer or non-health professional from UNITED STATES reported BEXTRA problem on Aug 20, 2007. Female patient, weighting 125.0 lb, was treated with BEXTRA. After drug was administered, patient experienced the following problems/side effects: visual field defect, . BEXTRA dosage: unknown. Patient recovered.
VISUAL FIELD DEFECT : Citalopram Side Effects Report #5442916-3
CITALOPRAM HYDROBROMIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 21, 2007. Female patient, 32 years of age, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: visual field defect, . CITALOPRAM HYDROBROMIDE dosage: 20 MG; BID; PO. Patient recovered.
VISUAL FIELD DEFECT : Citalopram Side Effects Report #5443313-7
Health Professional from DENMARK reported CITALOPRAM HYDROBROMIDE problem on Aug 17, 2007. Female patient, 32 years of age, was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: visual field defect, . CITALOPRAM HYDROBROMIDE dosage: 20 MG BID PO. Patient recovered.
VISUAL FIELD DEFECT : Doxil Side Effects Report #5378176-1
DOXIL problem was reported by a Physician from JAPAN on June 27, 2007. Male patient was diagnosed with kaposi's sarcoma, hiv infection, acquired immunodeficiency syndrome, cytomegalovirus oesophagitis, mycobacterium avium complex infection and was treated with DOXIL. After drug was administered, patient experienced the following problems/side effects: visual field defect, . DOXIL dosage: 30MG PER 3 TO 4 WEEKS. During the same period patient was treated with NORVIR, REYATAZ, EPZICOM, VALIXA, ZITHROMAC, ESANBUTOL, RIFABUTIN. Patient recovered.
VISUAL FIELD DEFECT : Ultravist Side Effects Report #5381122-8
Physician from GERMANY reported ULTRAVIST problem on June 27, 2007. Female patient, 65 years of age, was diagnosed with angiogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: visual field defect, . ULTRAVIST dosage: 90 ML, UNK. Patient recovered.
VISUAL FIELD DEFECT : Doxil Side Effects Report #5386423-5
DOXIL problem was reported by a Physician from JAPAN on July 05, 2007. Male patient was diagnosed with kaposi's sarcoma, hiv infection, acquired immunodeficiency syndrome, cytomegalovirus oesophagitis, mycobacterium avium complex infection and was treated with DOXIL. After drug was administered, patient experienced the following problems/side effects: visual field defect, . DOXIL dosage: 30MG PER 3 TO 4 WEEKS. During the same period patient was treated with NORVIR, REYATAZ, EPZICOM, VALIXA, ZITHROMAC, ESANBUTOL, RIFABUTIN. Patient recovered.
VISUAL FIELD DEFECT : Risperdal Side Effects Report #5389099-6
Physician from GERMANY reported RISPERDAL problem on July 12, 2007. Female patient, 43 years of age, was diagnosed with schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: visual field defect, . RISPERDAL dosage: unknown. During the same period patient was treated with VALPROATE, EUTHYROX. Patient recovered.
VISUAL FIELD DEFECT : Actos Side Effects Report #5390837-7
ACTOS problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 02, 2007. Female patient was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: visual field defect, . ACTOS dosage: 30 MG. During the same period patient was treated with GLICLAZIDE. Patient recovered.
VISUAL FIELD DEFECT : Norvasc Side Effects Report #5392801-0
Physician from JAPAN reported NORVASC problem on July 11, 2007. Male patient, weighting 129.4 lb, was diagnosed with hypertension and was treated with NORVASC. After drug was administered, patient experienced the following problems/side effects: visual field defect, . NORVASC dosage: unknown. During the same period patient was treated with CANDESARTAN CILEXETIL, ZESTRIL, LONGES. Patient recovered.
VISUAL FIELD DEFECT : Prevacid Side Effects Report #5398345-4
PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2007. Female patient, 43 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: visual field defect, . PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. Patient recovered.
VISUAL FIELD DEFECT : Prevacid Side Effects Report #5404172-1
Consumer or non-health professional from UNITED STATES reported PREVACID problem on July 19, 2007. Female patient, 43 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: visual field defect, . PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. Patient recovered.
VISUAL FIELD DEFECT : Doxil Side Effects Report #5378176-1
DOXIL problem was reported by a Physician from JAPAN on June 27, 2007. Male patient was diagnosed with kaposi's sarcoma, hiv infection, acquired immunodeficiency syndrome, cytomegalovirus oesophagitis, mycobacterium avium complex infection and was treated with DOXIL. After drug was administered, patient experienced the following problems/side effects: visual field defect, . DOXIL dosage: 30MG PER 3 TO 4 WEEKS. During the same period patient was treated with NORVIR, REYATAZ, EPZICOM, VALIXA, ZITHROMAC, ESANBUTOL, RIFABUTIN. Patient recovered.
VISUAL FIELD DEFECT : Ultravist Side Effects Report #5381122-8
Physician from GERMANY reported ULTRAVIST problem on June 27, 2007. Female patient, 65 years of age, was diagnosed with angiogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: visual field defect, . ULTRAVIST dosage: 90 ML, UNK. Patient recovered.
VISUAL FIELD DEFECT : Doxil Side Effects Report #5386423-5
DOXIL problem was reported by a Physician from JAPAN on July 05, 2007. Male patient was diagnosed with kaposi's sarcoma, hiv infection, acquired immunodeficiency syndrome, cytomegalovirus oesophagitis, mycobacterium avium complex infection and was treated with DOXIL. After drug was administered, patient experienced the following problems/side effects: visual field defect, . DOXIL dosage: 30MG PER 3 TO 4 WEEKS. During the same period patient was treated with NORVIR, REYATAZ, EPZICOM, VALIXA, ZITHROMAC, ESANBUTOL, RIFABUTIN. Patient recovered.
VISUAL FIELD DEFECT : Risperdal Side Effects Report #5389099-6
Physician from GERMANY reported RISPERDAL problem on July 12, 2007. Female patient, 43 years of age, was diagnosed with schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: visual field defect, . RISPERDAL dosage: unknown. During the same period patient was treated with VALPROATE, EUTHYROX. Patient recovered.
VISUAL FIELD DEFECT : Actos Side Effects Report #5390837-7
ACTOS problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 02, 2007. Female patient was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: visual field defect, . ACTOS dosage: 30 MG. During the same period patient was treated with GLICLAZIDE. Patient recovered.
VISUAL FIELD DEFECT : Norvasc Side Effects Report #5392801-0
Physician from JAPAN reported NORVASC problem on July 11, 2007. Male patient, weighting 129.4 lb, was diagnosed with hypertension and was treated with NORVASC. After drug was administered, patient experienced the following problems/side effects: visual field defect, . NORVASC dosage: unknown. During the same period patient was treated with CANDESARTAN CILEXETIL, ZESTRIL, LONGES. Patient recovered.
VISUAL FIELD DEFECT : Prevacid Side Effects Report #5398345-4
PREVACID problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2007. Female patient, 43 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: visual field defect, . PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. Patient recovered.
VISUAL FIELD DEFECT : Prevacid Side Effects Report #5404172-1
Consumer or non-health professional from UNITED STATES reported PREVACID problem on July 19, 2007. Female patient, 43 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with PREVACID. After drug was administered, patient experienced the following problems/side effects: visual field defect, . PREVACID dosage: 30 MG, 1 IN 1 D, PER ORAL. Patient recovered.
VISUAL FIELD DEFECT : Voltaren Side Effects Report #5646603-8
VOLTAREN problem was reported by a Consumer or non-health professional from FRANCE on Feb 25, 2008. Male patient, child 11 years of age, weighting 125.7 lb, was diagnosed with joint sprain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: eye movement disorder, visual field defect, . VOLTAREN dosage: 25 MG DAILY. Patient was hospitalized. Patient recovered.
VISUAL FIELD DEFECT : Celecox Side Effects Report #5654065-X
Health Professional from JAPAN reported CELECOX problem on Feb 25, 2008. Female patient, 85 years of age, was diagnosed with osteoarthritis and was treated with CELECOX. After drug was administered, patient experienced the following problems/side effects: dyscalculia, visual field defect, . CELECOX dosage: DAILY DOSE:200MG. Patient recovered.
VISUAL FIELD DEFECT : Ludiomil Side Effects Report #5659459-4
LUDIOMIL problem was reported by a Pharmacist from JAPAN on Mar 03, 2008. Male patient, 28 years of age, was diagnosed with depression and was treated with LUDIOMIL. After drug was administered, patient experienced the following problems/side effects: amnesia, visual field defect, . LUDIOMIL dosage: unknown. During the same period patient was treated with TOLEDOMIN, LENDORMIN, PEMOLINE, MYSLEE, WYPAX, LEXOTAN, DOGMATYL, ANAFRANIL. Patient recovered.
VISUAL FIELD DEFECT : Celecox Side Effects Report #5662214-2
Health Professional from JAPAN reported CELECOX problem on Feb 29, 2008. Female patient, 85 years of age, was diagnosed with osteoarthritis and was treated with CELECOX. After drug was administered, patient experienced the following problems/side effects: dyscalculia, visual field defect, . CELECOX dosage: DAILY DOSE:200MG. Patient recovered.
VISUAL FIELD DEFECT : Chantix Side Effects Report #5663060-6
CHANTIX problem was reported by a Physician from GERMANY on Mar 04, 2008. Male patient, weighting 198.4 lb, was diagnosed with nicotine dependence and was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: hemianopia, visual field defect, . CHANTIX dosage: unknown. Patient recovered.
VISUAL FIELD DEFECT : Celecox Side Effects Report #5676345-4
Physician from JAPAN reported CELECOX problem on Mar 11, 2008. Female patient, 85 years of age, was diagnosed with osteoarthritis and was treated with CELECOX. After drug was administered, patient experienced the following problems/side effects: dyscalculia, visual field defect, . CELECOX dosage: DAILY DOSE:200MG. Patient recovered.
VISUAL FIELD DEFECT : Femara Side Effects Report #5632923-X
FEMARA problem was reported by a Physician from FRANCE on Feb 12, 2008. Female patient, 70 years of age, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: corrective lens user, visual field defect, . FEMARA dosage: 2.5 MG, QD. Patient recovered.
VISUAL FIELD DEFECT : Viagra Side Effects Report #5633630-X
Consumer or non-health professional from UNITED STATES reported VIAGRA problem on Feb 14, 2008. Male patient was treated with VIAGRA. After drug was administered, patient experienced the following problems/side effects: optic ischaemic neuropathy, visual field defect, . VIAGRA dosage: unknown. Patient recovered.
VISUAL FIELD DEFECT : Pegasys Side Effects Report #5638889-0
PEGASYS problem was reported by a Physician from FRANCE on Feb 15, 2008. Female patient, 43 years of age, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: headache, visual field defect, . PEGASYS dosage: unknown. During the same period patient was treated with NEORECORMON, KALETRA, INVIRASE, REBETOL. Patient was hospitalized. Patient recovered.
VISUAL FIELD DEFECT : Voltaren Side Effects Report #5640555-2
Consumer or non-health professional from FRANCE reported VOLTAREN problem on Feb 25, 2008. Male patient, child 11 years of age, weighting 125.7 lb, was diagnosed with joint sprain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: eye movement disorder, visual field defect, . VOLTAREN dosage: 25 MG DAILY. Patient was hospitalized. Patient recovered.
VISUAL FIELD DEFECT : Nolvadex Side Effects Report #5584317-3
NOLVADEX problem was reported by a Physician from FRANCE on Jan 03, 2008. Female patient, weighting 114.6 lb, was diagnosed with breast cancer female and was treated with NOLVADEX. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced, visual field defect, . NOLVADEX dosage: unknown. During the same period patient was treated with TAMOXIFEN. Patient recovered.
VISUAL FIELD DEFECT : Sutent Side Effects Report #5590787-7
Pharmacist from IRELAND reported SUTENT problem on Jan 07, 2008. Male patient, 43 years of age, was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: eye pain, visual field defect, . SUTENT dosage: unknown. Patient recovered.
VISUAL FIELD DEFECT : Depakote Side Effects Report #5597679-8
DEPAKOTE problem was reported by a Physician from FRANCE on Jan 11, 2008. Male patient was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased, visual field defect, . DEPAKOTE dosage: unknown. During the same period patient was treated with SEROPLEX FILM, ARIPIPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LATANOPROST. Patient recovered.
VISUAL FIELD DEFECT : Escitalopram Side Effects Report #5599305-0
Health Professional from FRANCE reported ESCITALOPRAM problem on Jan 03, 2008. Male patient, 42 years of age, was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased, visual field defect, . ESCITALOPRAM dosage: 20 MG QD PO. During the same period patient was treated with ABILIFY, DEPAKOTE, XALATAN. Patient recovered.
VISUAL FIELD DEFECT : Chantix Side Effects Report #5605302-9
CHANTIX problem was reported by a Physician from SWEDEN on Jan 16, 2008. Female patient, 31 years of age, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: photopsia, visual field defect, . CHANTIX dosage: DAILY DOSE:1MG. Patient recovered.
VISUAL FIELD DEFECT : Enbrel Side Effects Report #5542495-6
Consumer or non-health professional from UNITED STATES reported ENBREL problem on Jan 03, 2007. Male patient was diagnosed with psoriasis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: vision blurred, visual field defect, . ENBREL dosage: unknown. Patient recovered.
VISUAL FIELD DEFECT : Enbrel Side Effects Report #5545041-6
ENBREL problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 20, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: optic nerve cup/disc ratio increased, visual field defect, . ENBREL dosage: unknown. Patient recovered.
VISUAL FIELD DEFECT : Citalopram Side Effects Report #5567406-9
Health Professional from UNITED KINGDOM reported CITALOPRAM HYDROBROMIDE problem on Dec 06, 2007. Female patient, 32 years of age, was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, visual field defect, . CITALOPRAM HYDROBROMIDE dosage: 40 MG (20 MG, 2 IN 1 D). Patient recovered.
VISUAL FIELD DEFECT : Citalopram Side Effects Report #5567533-6
CITALOPRAM problem was reported by a Health Professional from UNITED KINGDOM on Nov 29, 2007. Female patient, 32 years of age, weighting 165.3 lb, was diagnosed with depression and was treated with CITALOPRAM. After drug was administered, patient experienced the following problems/side effects: visual disturbance, visual field defect, . CITALOPRAM dosage: 40 MG; ORAL. During the same period patient was treated with CLINDAMYCIN, ERYTHROMYCIN, SERETIDE. Patient recovered.
VISUAL FIELD DEFECT : Avodart Side Effects Report #5569320-1
Consumer or non-health professional from UNITED STATES reported AVODART problem on Oct 30, 2007. Male patient, 79 years of age, was treated with AVODART. After drug was administered, patient experienced the following problems/side effects: dizziness, visual field defect, . AVODART dosage: .5MG ALTERNATE DAYS. During the same period patient was treated with CHLORDIAZEPOXID, TRAZODONE, TEMAZEPAM, CLONIDINE. Patient recovered.